Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Abatacept by Bristol-Myers Squibb for Immunoglobulin G4-Related Disease (IgG4-RD): Likelihood of Approval
Abatacept is under clinical development by Bristol-Myers Squibb and currently in Phase II for Immunoglobulin G4-Related Disease (IgG4-RD). According to...
Abatacept by Bristol-Myers Squibb for Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease): Likelihood of Approval
Abatacept is under clinical development by Bristol-Myers Squibb and currently in Phase II for Interstitial Lung Diseases (Diffuse Parenchymal Lung...
Abatacept by Bristol-Myers Squibb for Myocarditis: Likelihood of Approval
Abatacept is under clinical development by Bristol-Myers Squibb and currently in Phase III for Myocarditis. According to GlobalData, Phase III...
Abatacept by Bristol-Myers Squibb for Cytopenia: Likelihood of Approval
Abatacept is under clinical development by Bristol-Myers Squibb and currently in Phase II for Cytopenia. According to GlobalData, Phase II...